Market Cap
18504497152.00
CSL
Carlisle Companies Incorporated
Exchange: nyse
Multiples
- P/E: 21.91
- P/BV: 6.69
- P/TBV: 11.38
Description:
CSL is the ticker symbol for CSL Limited, a leading global biotechnology company listed on the New York Stock Exchange (NYSE). Headquartered in Melbourne, Australia, CSL specializes in the development and delivery of life-saving therapies across a range of therapeutic areas including immunology, neuroscience, and rare blood disorders. The company has a strong track record of innovation and growth, driven by its commitment to research and development, as well as strategic acquisitions that have expanded its product portfolio and market presence worldwide.
Data:
Yields:
Earnings Yield
1.748418944744
Return on Capital
0.265185079886
CAGR (net income)
46.94%
CAGR Length
3.75
Dividend Rate
4.000000
